Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 6
2011 2
2012 1
2013 1
2014 2
2015 5
2016 8
2017 2
2018 2
2019 5
2020 4
2021 9
2022 11
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Impact of lens autofluorescence and opacification on retinal imaging.
von der Emde L, Rennen GC, Vaisband M, Hasenauer J, Liegl R, Fleckenstein M, Pfau M, Holz FG, Ach T. von der Emde L, et al. Among authors: ach t. BMJ Open Ophthalmol. 2024 Apr 29;9(1):e001628. doi: 10.1136/bmjophth-2023-001628. BMJ Open Ophthalmol. 2024. PMID: 38684375 Free article.
Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration".
Grisanti S, Bartz-Schmidt KU, Heimann H, Lommatzsch A, Walter P, Ach T. Grisanti S, et al. Among authors: ach t. Ophthalmol Ther. 2024 Apr;13(4):1051-1053. doi: 10.1007/s40123-024-00894-2. Epub 2024 Feb 6. Ophthalmol Ther. 2024. PMID: 38319554 Free PMC article. No abstract available.
Lysolipids are prominent in subretinal drusenoid deposits, a high-risk phenotype in age-related macular degeneration.
Anderson DMG, Kotnala A, Migas LG, Patterson NH, Tideman L, Cao D, Adhikari B, Messinger JD, Ach T, Tortorella S, Van de Plas R, Curcio CA, Schey KL. Anderson DMG, et al. Among authors: ach t. Front Ophthalmol (Lausanne). 2023;3:1258734. doi: 10.3389/fopht.2023.1258734. Epub 2023 Nov 24. Front Ophthalmol (Lausanne). 2023. PMID: 38186747 Free PMC article.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Retest variability and patient reliability indices of quantitative fundus autofluorescence in age-related macular degeneration: a MACUSTAR study report.
von der Emde L, Mallwitz M, Vaisband M, Hasenauer J, Saßmannshausen M, Terheyden JH; MACUSTAR Consortium; Sloan KR, Schmitz-Valckenberg S, Finger RP, Holz FG, Ach T. von der Emde L, et al. Among authors: ach t. Sci Rep. 2023 Oct 13;13(1):17417. doi: 10.1038/s41598-023-43417-y. Sci Rep. 2023. PMID: 37833348 Free PMC article.
71 results